FindTrial
Sign In

Optimization of an IBD Self-management Support App and Evaluation of Its Intervention Effect

Optimization of an IBD Self-management Support App and Evaluation of Its Intervention Effect: A Practice Study Integrating a RAG-DeepSeek Model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119407
Enrollment
Unknown
Registered
2026-02-26
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Stage I - Control Group:Routine management with standard health education and guidance in outpatient or inpatient settings (adherence to prescribed medication, diet and exercise, follow-up visits, and
Stage I - Trial Group:Routine management plus Chang Xiang Sui APP intervention (health education content library with personalized, symptom tracking and reminders, medication reminders, AI-powered int
Stage II - Control Group:Routine management with standard health education and guidance in outpatient or inpatient settings (adherence to prescribed medication, diet and exercise, follow-up visits, an
Stage II - Trial Group:Routine management plus Chang Xiang Sui APP intervention (health education content library with personalized, symptom tracking and reminders, medication reminders, AI-powered in

Sponsors

The Second Affiliated Hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed IBD (UC or CD); 2. =18 years old; 3. Possess basic smartphone/tablet operation skills; 4. Voluntarily sign the informed consent form and be able to follow up as planned; 5. The condition is relatively stable, and the doctor's assessment is appropriate; 6.Able to complete basic APP operation training (registration and login, symptom recording, Q&A/knowledge query).

Exclusion criteria

Exclusion criteria: 1. Acute severe attack or serious complications/critical condition; 2.Significant cognitive impairment or severe mental illness; 3. Participate in other interventional studies that may affect the outcome concurrently; 4.Those who are unable to continue using smart devices or are unable to complete follow-up.

Design outcomes

Secondary

MeasureTime frame
Quality of Life;Disease Activity;Disease Knowledge;Healthcare Utilization;Safety Outcomes (including adverse events related to digital intervention, serious adverse events, and general adverse events);—

Primary

MeasureTime frame
IBD Self-Management Behavior Scale (36 items, 7 dimensions, Likert 5-point scale, total score 36–180);—

Countries

China

Contacts

Public ContactChen Yan

The Second Affiliated Hospital of Zhejiang University

chenyan72_72@zju.edu.cn+86 137 5711 8653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026